Published in Commun Dis Rep CDR Rev on October 14, 1994
Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis (2002) 3.32
DNA fingerprinting of Salmonella enterica subsp. enterica serovar typhimurium with emphasis on phage type DT104 based on variable number of tandem repeat loci. J Clin Microbiol (2003) 2.28
Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients. Antimicrob Agents Chemother (1999) 2.26
Characterization of Salmonella enterica serovar typhimurium DT104 isolated from Denmark and comparison with isolates from Europe and the United States. J Clin Microbiol (2000) 2.10
Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. Can Vet J (1998) 1.87
Identification of DT104 and U302 phage types among Salmonella enterica serotype typhimurium isolates by PCR. J Clin Microbiol (2000) 1.60
Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect (2006) 1.57
Characterization and chromosomal mapping of antimicrobial resistance genes in Salmonella enterica serotype typhimurium. Appl Environ Microbiol (2000) 1.46
Molecular characterization of Irish Salmonella enterica serotype typhimurium: detection of class I integrons and assessment of genetic relationships by DNA amplification fingerprinting. Appl Environ Microbiol (2000) 1.31
Exposure to rumen protozoa leads to enhancement of pathogenicity of and invasion by multiple-antibiotic-resistant Salmonella enterica bearing SGI1. Infect Immun (2005) 1.28
Household contamination with Salmonella enterica. Emerg Infect Dis (2003) 1.26
Emergence of multidrug-resistant Salmonella Paratyphi B dT+, Canada. Emerg Infect Dis (2004) 1.05
Phenotypic and molecular typing of Salmonella strains reveals different contamination sources in two commercial pig slaughterhouses. Appl Environ Microbiol (2004) 1.03
A beef-associated outbreak of Salmonella Typhimurium DT104 in The Netherlands with implications for national and international policy. Epidemiol Infect (2007) 1.00
An ecological approach to assessing the epidemiology of antimicrobial resistance in animal and human populations. Proc Biol Sci (2011) 0.99
Involvement of a Salmonella genomic island 1 gene in the rumen protozoan-mediated enhancement of invasion for multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium. Infect Immun (2006) 0.99
Animal-to-human transmission of Salmonella Typhimurium DT104A variant. Emerg Infect Dis (2004) 0.99
Survival and filamentation of Salmonella enterica serovar enteritidis PT4 and Salmonella enterica serovar typhimurium DT104 at low water activity. Appl Environ Microbiol (2000) 0.98
Survival of Salmonella enterica in freshwater and sediments and transmission by the aquatic midge Chironomus tentans (Chironomidae: Diptera). Appl Environ Microbiol (2003) 0.96
Characterization of Salmonella enterica serotype Typhimurium isolates from human, food, and animal sources in the Republic of Ireland. J Clin Microbiol (2004) 0.95
Habituation of Salmonella spp. at reduced water activity and its effect on heat tolerance. Appl Environ Microbiol (2000) 0.93
Genetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animals. Front Microbiol (2013) 0.89
Salmonella virchow PT 26 infection in England and Wales: a case control study investigating an increase in cases during 1994. Epidemiol Infect (1996) 0.80
Emergence of Salmonella typhimurium definitive type 104 (DT104) as an important cause of salmonellosis in horses in Ontario. Can Vet J (2001) 0.80
Surveillance of multidrug-resistant strains of Salmonella enterica serotype Typhimurium in southern Italy in the years 1992-1997. Eur J Epidemiol (2000) 0.79
The prevalences of Salmonella Genomic Island 1 variants in human and animal Salmonella Typhimurium DT104 are distinguishable using a Bayesian approach. PLoS One (2011) 0.77
Distribution of Salmonella in tissues following natural and experimental infection in pigs. Can J Vet Res (2004) 0.77
Polymorphism of gene cassette promoter variants of class 1 integron harbored in S. Choleraesuis and Typhimurium isolated from Taiwan. Biomedicine (Taipei) (2014) 0.75
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Bacteriophage-typing designations of Salmonella typhimurium. J Hyg (Lond) (1977) 8.59
A phage-typing scheme for Salmonella enteritidis. Epidemiol Infect (1987) 7.42
International increase in Salmonella enteritidis: a new pandemic? Epidemiol Infect (1990) 5.94
Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet (2000) 5.93
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med (1998) 5.78
Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature (1996) 5.50
An investigation of traveller's diarrhoea. Lancet (1970) 4.99
Clonal distribution of resistance plasmid-carrying Salmonella typhimurium, mainly in the Middle East. J Hyg (Lond) (1977) 4.46
Clonal lines of Salmonella enterica serotype Enteritidis documented by IS200-, ribo-, pulsed-field gel electrophoresis and RFLP typing. J Med Microbiol (1994) 4.43
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Salmonella enteritidis phage type 4 infection: association with hen's eggs. Lancet (1988) 4.31
Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet (1998) 4.11
Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis (1997) 3.91
Epidemic in cattle and humans of Salmonella typhimurium DT 104 with chromosomally integrated multiple drug resistance. Vet Rec (1994) 3.91
X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90
Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet (1987) 3.79
Case-control study of infections with Salmonella enteritidis phage type 4 in England. BMJ (1989) 3.79
Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet (1999) 3.78
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet (1996) 3.77
Ciprofloxacin-resistant Salmonella typhimurium DT104. Vet Rec (1998) 3.61
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol (1985) 3.60
Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain. J Hyg (Lond) (1986) 3.60
Ciprofloxacin and typhoid fever. Lancet (1992) 3.59
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth (2001) 3.47
Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis (2001) 3.35
Aftermath of surgery for anorectal cancer. Br Med J (1971) 3.27
Economic evaluation of robot-assisted hysterectomy: a cost-minimisation analysis. BJOG (2014) 3.25
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol (1988) 3.25
Application of pulsed-field gel electrophoresis to an international outbreak of Salmonella agona. Emerg Infect Dis (1996) 3.22
Treatment of multiresistant typhoid fever. Lancet (1991) 3.18
Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli. J Clin Microbiol (1977) 3.11
Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child (1990) 3.04
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104. Microb Drug Resist (1998) 2.99
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect (1987) 2.98
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Outbreak of Salmonella napoli infection caused by contaminated chocolate bars. Lancet (1983) 2.82
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet (1991) 2.80
Serological analysis of chicken flocks for antibodies to Salmonella enteritidis. Vet Rec (1990) 2.79
Spread of multiresistant strains of Salmonella typhimurium phage types 204 and 193 in Britain. Br Med J (1978) 2.71
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans. Infect Immun (1982) 2.62
Increasing spectrum of resistance in multiresistant Salmonella typhimurium. Lancet (1996) 2.58
Corrective shoes and inserts as treatment for flexible flatfoot in infants and children. J Bone Joint Surg Am (1989) 2.56
Salmonella enteritidis phage type 4 from the contents of intact eggs: a study involving naturally infected hens. Epidemiol Infect (1989) 2.52
New fimbrial antigenic type (E8775) that may represent a colonization factor in enterotoxigenic Escherichia coli in humans. Infect Immun (1982) 2.52
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) (1986) 2.47
Subdivision of Salmonella enteritidis PT 4 by pulsed-field gel electrophoresis: potential for epidemiological surveillance. FEMS Microbiol Lett (1994) 2.44
Neonatal meningitis caused by Citrobacter koseri. J Clin Pathol (1973) 2.43
Blood pressure survey in pregnancy. Clin Sci (1969) 2.42
The effects of positive and negative social exchanges on aging adults. J Gerontol B Psychol Sci Soc Sci (1997) 2.40
Poultry meat as a source of human salmonellosis in England and Wales. Epidemiological overview. Epidemiol Infect (1988) 2.38
Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension (1995) 2.36
The Second National Prevalence Survey of infection in hospitals--overview of the results. J Hosp Infect (1996) 2.32
Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K. Lancet (1976) 2.31
Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol (1991) 2.28
Investigation of outbreaks of salmonella in hospitals. Br Med J (Clin Res Ed) (1983) 2.27
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis (1992) 2.23
Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21
Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg (2005) 2.19
Use of systematic reviews of randomised trials by Australian neonatologists and obstetricians. Med J Aust (1998) 2.18
The pharmacokinetics of combination therapy with nelfinavir plus nevirapine. AIDS (1998) 2.16
Incentive spirometry decreases respiratory complications following major abdominal surgery. Surgeon (2007) 2.15
Subdivision of Salmonella enteritidis phage types by plasmid profile typing. Epidemiol Infect (1989) 2.15
Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens. J Clin Microbiol (1998) 2.14
The emergence of ciprofloxacin resistance in Salmonella typhimurium. J Antimicrob Chemother (1990) 2.13
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol (2007) 2.13
The possession of three novel coli surface antigens by enterotoxigenic Escherichia coli strains positive for the putative colonization factor PCF8775. J Gen Microbiol (1985) 2.12
Acquisition of a drug resistance plasmid converts Salmonella enteritidis phage type 4 to phage type 24. Epidemiol Infect (1989) 2.11
Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol (1989) 2.08
Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis (2008) 2.06
The role of Shigella spp., enteroinvasive Escherichia coli, and other enteropathogens as causes of childhood dysentery in Thailand. J Infect Dis (1986) 2.06
Correlation of phaga type, biotype and source in strains of Salmonella typhimurium. J Hyg (Lond) (1978) 2.05
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun (1998) 2.02
Food poisoning: notifications, laboratory reports, and outbreaks--where do the statistics come from and what do they mean? Commun Dis Rep CDR Rev (1996) 2.01